Heparin versus saline to keep IV line working
This trial compares using heparin (a blood-thinning medicine) versus saline (salt water) to keep a peripheral IV line open and working. It may help reduce line blockage and improve how well IV treatments can be given.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old and staying at Hospital Residencia Sant Camil
- You have an IV line in a hand/arm that is used intermittently (not placed for a medical emergency)
- You can sign a consent form to join the study
- You do not have an allergy to heparin
- You are not already on a type of heparin called unfractionated sodium heparin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether blood samples taken from a central line using either a syringe flush or a vacuum tube give the same heparin activity results as blood from a vein in the arm. It is designed for patients in the ICU who are on a steady heparin drip.
This trial tests whether giving heparin (a blood thinner) during a specific type of heart procedure is safer and works better than not giving it. It focuses on patients where the blood supply in the hand’s artery connection is functioning properly.
This trial tests whether giving a blood-thinner called heparin to all patients during a procedure through the wrist (radial artery) is better than giving it only when needed. The goal is to see which approach reduces the risk of the artery getting blocked afterward.
This study tests whether adding a low dose of a blood thinner called apixaban (also known as Eliquis) to the standard solution used to keep dialysis catheters open will help prevent them from getting blocked. It could improve the reliability of your dialysis treatments and reduce the need for catheter replacements.
This trial tests whether giving a blood thinner before placing a central line (a special IV) helps prevent clots in critically ill children. It could lower the risk of problems from the line.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Hear when a new Catheter Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.